TenQ · Equity ReportCharts view ⇢  Fact sheet  Updated 2026-09-04

Honeywell InternationalHON

$66.4B market cap

Makes aerospace parts, building controls, industrial automation and specialty materials.

$209.61-18.7% from 52-week high · delayed close as of 2026-09-04 · not investment advice
+0.9% vs S&P 500 (SPY) +20.3% over twelve months
$189.62$207.96$226.31$244.66$263.00Sep '25Nov '25Jan '26Apr '26Jun '26Sep '26
The verdict

Honeywell International in 36 checks

Honeywell International at a glance: how it scores on value, growth, quality, health, shareholder returns and trend. The fuller the shape, the stronger the company. Behind each axis are six pass-or-fail checks from its filings, spelled out in the chapters below. Point at an axis to see them.

VALUEGROWTHQUALITYHEALTHRETURNSTREND

A mixed picture - strengths and real weaknesses - 20 of 36 checks passed.

Advertisement
I

Value

●●●●●●3/6

What you pay today for what the business produces, measured against HON's own history and its peers, never a universal rule.

Fairly priced on some measures, rich on others - earnings multiple below its own long-run norm.

16.4xown 11-year median 21x
1.7xown 11-year median 3x
6.0%cash earned per $ of price
9.4xwhole-business multiple
Today’s multiple

Is the price high or low right now, compared to what the market usually pays?

11-year median 21xP/E today 16.4x

At 16.4x earnings, the market is paying 23% less than HON's own 11-year median of 21.3x. Pessimism is priced in - the question is whether it is deserved.

Valuation history

What has the market paid for HON over the years?

0.0020.0040.0020152016201720182019202020212022202320242025202611-year median 21.3xP/E 16.41

2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages

At 16.4x earnings, the market is paying 23% less than HON's own 11-year median of 21.3x. Pessimism is priced in - the question is whether it is deserved.

Free cash flow yield

What cash return does the business throw off per dollar of market value?

6.0%FCF yield today

0.0%5.0%20152016201720182019202020212022202320242025202611-year median 5.2%FCF yield 6.0%

2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages

At 6.0%, the business is throwing off more cash per dollar of market value than its own 11-year median of 5.2% - the cheaper end of its history.

What does “Value” actually mean?

Value asks what you pay for each dollar of earnings, sales or cash the business produces. A high multiple isn't automatically bad - fast growers earn theirs - but a price far above the company's own history means the market expects a lot to go right. We compare each multiple to the company's own past and to its sector, never to a universal rule.

How we scored it · 3 of 6 checks passed
Cheaper than its own history (earnings)no multiple history
Earnings yield beats a long bond (4%)6.1% vs 4.0%
Better cash yield than its own historyunder 3 years of cash-flow history
Free cash flow yield above 3%6.0% vs 3.0%
Cheap on enterprise value9.36 vs 14.00 (peer median)
Price isn't outrunning growthPEG 41.25
II

Growth

●●●●●●3/6

What the company has actually reported - is it selling more, and is more of it becoming profit?

Growing, but with caveats - revenue +5.0% over the last year.

+5.0%vs the year before
+1.8%compound annual
+43.7%net income growth
+0.4%compound annual
Revenue history

Revenue: is the business selling more than it used to?

0.00$20.0B$40.0B20112012201320142015201620172018$41.8B20192020202120222023202420252026$38.1B

◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year

Revenue reached $37.4B in 2025, compounding +2% a year since 2022 and the pace is picking up.

Profit history

Net income: how much of that revenue becomes profit?

0.00$5.0B2011201220132014201520162017201820192020202120222023202420252026$8.2B

◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year

Net income was $4.7B in 2025, compounding -2% a year over three years. Earnings per share moved +44% over the last twelve months. Trailing twelve-month profit stands at $8.2B.

Growth rate

How fast is it growing, year by year?

+8%revenue growth, FY 2025

-50%0.0%201220132014201520162017201820192020202120222023202420257.8%-17%

Shown separately because they would flatten the axis: 2018 earnings +338% - rebounds off a collapsed prior year.

In 2025 revenue grew +8% while earnings moved -17% - when the earnings line runs above revenue, each new dollar of sales is arriving more profitably.

Per-share growth

Revenue per share: is your slice growing as fast as the company?

$58.25revenue per share, FY 2025

0.0025.0050.00201120122013201420152016201720182019202020212022202320242025202659.216.24

2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year

Revenue per share reached $58.25 in 2025, compounding +4% a year against +2% for HON as a whole. Buybacks added roughly 2.1 points to your per-share result. Free cash flow per share stands at $8.43.

What does “Growth” actually mean?

Growth here is what the company has actually reported to the SEC - not a forecast. We look at the last year, the three-year pace, whether growth is speeding up or slowing down, and whether it's been consistent rather than one lucky year. Hatched bars are fourth quarters we derived from annual filings (companies file a full-year 10-K rather than a Q4 report).

How we scored it · 3 of 6 checks passed
Outgrew its sector last year5.0% vs 12.1% (sector 70th pct, n=84)
Sustained growth beats its sector (3 years)1.8% vs 13.9% (sector 70th pct, n=72)
Profits grew last year43.7% vs 0.0%
Profit growth beats its peers0.4% vs 10.7% (sector 70th pct, n=47)
Growth is speeding up, not slowing1y 5.0% vs 3y 1.8%
Grew per share, not just in total12.2% vs 0.0%
III

Quality

●●●●●5/6

Whether the growth makes real money - margins, returns on capital, and whether profits turn into cash.

Rare profitability: margins and returns on capital are well above its peers.

36.3%kept after direct costs
22.0%kept after running costs
44.3%profit on shareholders' money
15.4%against a 10% cost of capital
62%operating cash ÷ net income
Margins

Margins: of every $1 of sales, how much survives each cost layer?

0.0%20%201120122013201420152016201720182019202020212022202320242025202636%22%22%

2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year

Operating margin has held near 22% since 2022. After everything, 13 cents of each sales dollar reaches net profit.

Earnings quality

Earnings quality: do the reported profits turn into real cash?

0.00$5.0B2011201220132014201520162017201820192020202120222023202420252026$5.1B$8.2B

2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year

Only 62% of reported profit becomes operating cash. Accounting profit is running ahead of cash collection, which is worth watching in the receivables and inventory lines.

Returns on capital

What does it earn on the money it uses?

0.0%20%40%201120122013201420152016201720182019202020212022202320242025202644%11%16%

2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year

ROE of 34% but ROCE of only 16% - a chunk of those shareholder returns is manufactured with leverage, not operations.

Cash conversion

How much of every sales dollar ends up as free cash?

0.0%10%20112012201320142015201620172018201917%202020212022202320242025202611%

◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year

14 cents of every sales dollar became free cash in 2025, and it has held steady since 2022.

Spending intensity

What does staying competitive cost, per dollar of sales?

0.0%2.0%4.0%20112012201320142015201620172018201920202021202220232024202520262.9%5.1%0.5%

2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year

The biggest claim on each sales dollar is research and development, at 5% of revenue (capital spending 3%, stock compensation 1%). That share has risen since 2022, so the cost of competing is climbing.

Return on capital employed

Does HON earn more on its capital than that capital costs?

0.0%10%20%202220232024202510% cost-of-capital lineReturn on capital 16%

HON earns 16.2% on the capital it employs, comfortably above the 10% most investors treat as the cost of capital. It was 18.9% in 2022, so the trend is down, though the pace has cooled.

What does “Quality” actually mean?

Quality asks whether the growth makes real money. Margins show how much of each sale survives costs; return on equity shows what shareholders earn on their capital; and the profit-to-cash comparison catches companies whose accounting profits never turn into actual cash.

How we scored it · 5 of 6 checks passed
Better gross margins than peers36.3% vs 25.3% (sector 70th pct, n=68)
Runs leaner than peers (operating margin)22.0% vs 8.2% (sector 70th pct, n=78)
Actually profitableTTM net income $8.2B
Earns well on shareholders' money44.3% vs 11.8% (sector 70th pct, n=74)
Earns a real return on the capital it employs15.4% vs 10.0%
Profits are cash, not accounting0.62 vs 0.80
IV

Health

●●●●●●2/6

The balance sheet stress test: could HON survive a bad year?

The balance sheet carries real risk - read the checks before anything else.

1.83xborrowed vs owned
1.2xnear-term bills coverage
-earnings ÷ interest bill
$9.2Bcash plus short-term investments
Debt & cash

Could it handle its debt if things went wrong?

0.00$20.0B201220132014201520162017201820192020202120222023202420252026$34.0B$8.8B

2026 = the latest balance sheet (2026-06-30), not a fiscal year-end

Debt of $34.0B sits against $9.2B of cash, or 1.8x shareholders' equity.

Shareholders' equity

Is the company's own capital growing or shrinking?

0.00$10.0B$20.0B20122013201420152016$19.4B2017201820192020202120222023202420252026$18.5B

The company's own capital grew from $15.9B in 2023 to $18.5B (+17%). The business is building book value rather than consuming it.

What does “Health” actually mean?

Health asks one question: can the business survive a bad year? We check whether near-term bills are covered, whether debt is modest and shrinking, whether earnings comfortably pay the interest, and - for loss-makers - how many years of cash are left at the current burn rate.

How we scored it · 2 of 6 checks passed
Comfortable near-term liquidity1.21 vs 1.50
Debt isn't dominating1.83 vs 1.00
Debt trending the right waydebt/equity 1.83 now vs 1.06 five years ago
Could repay its debt from three years of operating cash6.64 vs 3.00
Converts sales to cash better than its sector13.4% vs 9.8% (sector 70th pct, n=86)
Self-fundingTTM free cash flow $4.0B
V

Shareholder returns

●●●●●5/6

How much cash actually flows back to owners - dividends, buybacks, whether the share count truly falls, and whether what is handed back is affordable.

Owners are paid reliably and affordably, and the share count is not eroding their stake.

$4.3Bdividends plus buybacks
$3.0Blast fiscal year
$3.8Blast fiscal year
$196Mdilutes the buybacks
-18.8%since 2011 (as reported)
Capital returned vs stock comp

How much goes back to shareholders - and how much leaks out as stock compensation?

0.00$2.0B$4.0B201120122013201420152016201720182019202020212022202320242025

$6.8B returned last year against $196M of stock issued to employees - the returns outweigh the dilution 34.6-to-1.

Dilution rate (split-adjusted)

How fast is your ownership being diluted - or concentrated?

-2.0%0.0%201220130.7%201420152016201720182019202020212022202320242025-1.9%

The count shrank 1.9% last year - buybacks are outrunning stock compensation.

Dividend per share (split-adjusted)

Is the dividend cheque itself growing?

0.002.004.00201120122013201420152016201720182019202020212022202320242025DPS 4.63

Up from $3.64 to $4.63 per share over 5 years - the cheque keeps growing.

Dividend yield

What does the payout earn you at each year's prices?

0.0%2.0%4.0%201520162017201820192020202120222023202420252026Yield 4.5%

2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages

At today's price the yield is 4.5%.

Payout quality

Can it actually afford the dividend?

0.0%50%100%201120122013201420152016201720182019202020212022202320242025202636%74%

2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year

Stretched: 63% of profits and 55% of free cash flow go out as dividends - most of what the business generates, so a cut gets likelier in a bad year.

Dilution against what it bought

HON has issued or retired shares - did shareholders end up better off?

05010020112012201320142015201620172018201920202021202220232024202581126

Both lines start at 100 in 2011, so the gap between them is what each share gained or lost. Share counts are split-adjusted.

HON has shrunk its share count -19% from 2011 to 2025, so each remaining share owns more of the business. Revenue per share is +26% over the same years.

Why compare buybacks with stock compensation?

A company can trumpet billions in buybacks while quietly issuing nearly as much stock to employees. What matters to you is the net effect: is the share count actually falling? If not, the 'return' is mostly recycling.

How we scored it · 5 of 6 checks passed
Share count isn't climbingshares down 5.9% over 3 years
Buybacks outpace the stock issued to staff$1.2B bought back vs $198M of stock compensation
What it hands back fits inside its cash flow106.6% vs 100.0%
Meaningful yield to owners (dividends and buybacks)$4.3B returned, 6.4% of market value
Reliable payer, never cutpaid 10/10 years, worst year-on-year change 1.3%
Dividend growing ahead of inflation9.5% vs 9.0%
VI

Trend analysis

●●●●●●2/6

What the market is doing about all of the above. This is price behaviour, not a fact about the business - read it as the market's current opinion, scored on six checks like every other chapter. The market is the S&P 500, measured by the SPY ETF with dividends included, over 3 months (63 trading sessions) and 12 months (252).

The market is voting against it right now - a falling trend on most measures.

-8.1%the long-term trend line
-6.3%S&P 500 (SPY): +4.7%
+0.5%S&P 500 (SPY): +20.0%
-18.7%drawdown from peak
Trend

How is HON's trend actually behaving right now?

Price chart loads as you scroll…

Chart by TradingView

HON is in a downtrend. The price is below the band where recent trading settled and that band is still falling, so nothing in the picture has turned yet. Both the last two weeks and the month-ago comparison point down as well, so nothing here disagrees with the downtrend. The band drawn for the coming weeks turns downward partway through, so that support is set to thin out from there.

How the trend above is worked out

The trend read comes from the daily Ichimoku picture, a standard trend indicator, translated out of its jargon. It builds a band from the midpoints of the last 9, 26 and 52 sessions' highs and lows - in effect, the range where recent trading has settled - and draws that band 26 sessions into the future. Price above the band is an uptrend, below it a downtrend, inside it no trend. Because the band is drawn forward, the support for the next few weeks is already fixed and a change of its direction can be seen coming. We also compare the last two weeks against the last month, and today's price against where it stood a month ago. None of this says anything about the business; it describes the price only, and it is not advice. Where a check says 'the S&P 500', the comparison is with the SPY ETF including dividends, on the same adjusted basis as the stock's own price: short means 3 months, 63 trading sessions; long means 12 months, 252.

How we scored it · 2 of 6 checks passed
Trading above its cloud0.00 vs 0.50
Long-term trend structure is healthy228.43 vs 227.98
Rising over 3 months-6.3% vs 0.0%
Beating the S&P 500 over 3 months-6.3% vs 4.7%
Beating the S&P 500 over 12 months0.5% vs 20.0%
Not in a deep hole-18.7% from its 52-week high
VII

Insider activity

informational

What the people running the company do with their own shares - reported to the SEC within two days, classified so pay-plumbing doesn't masquerade as conviction.

$0.00their own money
$4Moften pre-scheduled
7of the last filings
37grants · exercises · tax
Open-market flow

Are the people running it buying or selling with their own money?

$4M$2M0.00Jul '26Aug '26

No open-market buying, and $4M of selling across 2 months. Selling alone is a weak signal - much of it is pre-scheduled - but the absence of buying tells you no insider saw the price as a bargain.

The record

Who did what, exactly?

DateInsiderRoleTypeSharesValue
2026-08-03Kenneth J WestPres/CEO Process TechnologiesSELL316$77,569
2026-08-01Jennifer J ReillySVP and CHROtax325$78,653
2026-08-01Michal StepniakSrVP & Chief Financial Officertax175$42,352
2026-08-01Su Ping LuSrVP, General Counsel, CorpSectax167$40,416
2026-07-30Michal StepniakSrVP & Chief Financial Officertax263$63,091
2026-07-30Kenneth J WestPres/CEO Process Technologiestax215$51,576
2026-07-30Su Ping LuSrVP, General Counsel, CorpSectax205$49,177
2026-07-28Billal HammoudPres/CEO Building Automationtax158$39,350
2026-07-28Vimal KapurChief Executive Officertax131$32,626
2026-07-27Kenneth J WestPres/CEO Process Technologiesexercise1,531$296,738
Why do the transaction types matter so much?

Most insider filings are not trades: stock grants, option exercises and tax withholding are how executives get paid, and gifts are estate planning. The signal lives in open-market transactions - a buy means an insider chose to spend their own cash on the stock. Sells are murkier: many are pre-scheduled 10b5-1 plans set months in advance. That's why the chart counts only open-market activity, and the table labels every row.

§

Recent filings

  • 10-Q Quarterly report
  • 10-Q Quarterly report
  • DEF 14A Proxy statement
  • 10-K Annual report
  • 10-Q Quarterly report
  • 10-Q Quarterly report
  • 10-Q Quarterly report
  • DEF 14A Proxy statement
A short weekly note on what changed in the numbers, coming soon.One email a week: the charts that mattered, nothing else.